XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   900      
Beginning balance at Dec. 31, 2021 $ 19,514 $ 1 $ 25,887 $ (6,374) $ 0
Stockholders' Equity          
Capital stock issuance (in shares)   1      
Capital stock issuance 1   1    
Stock-based compensation 338   338    
Net loss (1,593)     (1,593)  
Ending balance (in shares) at Mar. 31, 2022   901      
Ending balance at Mar. 31, 2022 18,260 $ 1 26,226 (7,967) 0
Beginning balance (in shares) at Dec. 31, 2021   900      
Beginning balance at Dec. 31, 2021 19,514 $ 1 25,887 (6,374) 0
Stockholders' Equity          
Other comprehensive loss (4)        
Net loss (5,029)        
Ending balance (in shares) at Sep. 30, 2022   921      
Ending balance at Sep. 30, 2022 15,337 $ 1 26,743 (11,403) (4)
Beginning balance (in shares) at Mar. 31, 2022   901      
Beginning balance at Mar. 31, 2022 18,260 $ 1 26,226 (7,967) 0
Stockholders' Equity          
Capital stock issuance (in shares)   15      
Capital stock issuance 57   57    
Stock-based compensation 264   264    
Other comprehensive loss (1)       (1)
Net loss (1,712)     (1,712)  
Ending balance (in shares) at Jun. 30, 2022   916      
Ending balance at Jun. 30, 2022 16,868 $ 1 26,547 (9,679) (1)
Stockholders' Equity          
Capital stock issuance (in shares)   5      
Capital stock issuance 7   7    
Stock-based compensation 189   189    
Other comprehensive loss (3)       (3)
Net loss (1,724)     (1,724)  
Ending balance (in shares) at Sep. 30, 2022   921      
Ending balance at Sep. 30, 2022 $ 15,337 $ 1 26,743 (11,403) (4)
Beginning balance (in shares) at Dec. 31, 2022 926 926      
Beginning balance at Dec. 31, 2022 $ 13,799 $ 1 26,926 (13,126) (2)
Stockholders' Equity          
Capital stock issuance (in shares)   13      
Capital stock issuance 5   5    
Stock-based compensation 286   286    
Other comprehensive loss 1       1
Net loss (1,349)     (1,349)  
Ending balance (in shares) at Mar. 31, 2023   939      
Ending balance at Mar. 31, 2023 $ 12,742 $ 1 27,217 (14,475) (1)
Beginning balance (in shares) at Dec. 31, 2022 926 926      
Beginning balance at Dec. 31, 2022 $ 13,799 $ 1 26,926 (13,126) (2)
Stockholders' Equity          
Other comprehensive loss 0        
Net loss $ (3,911)        
Ending balance (in shares) at Sep. 30, 2023 956 956      
Ending balance at Sep. 30, 2023 $ 10,552 $ 1 27,590 (17,037) (2)
Beginning balance (in shares) at Mar. 31, 2023   939      
Beginning balance at Mar. 31, 2023 12,742 $ 1 27,217 (14,475) (1)
Stockholders' Equity          
Capital stock issuance (in shares)   7      
Capital stock issuance 34   34    
Stock-based compensation 132   132    
Other comprehensive loss 1       1
Net loss (1,195)     (1,195)  
Ending balance (in shares) at Jun. 30, 2023   946      
Ending balance at Jun. 30, 2023 11,714 $ 1 27,383 (15,670) 0
Stockholders' Equity          
Capital stock issuance (in shares)   10      
Capital stock issuance 2   2    
Stock-based compensation 205   205    
Other comprehensive loss (2)       (2)
Net loss $ (1,367)     (1,367)  
Ending balance (in shares) at Sep. 30, 2023 956 956      
Ending balance at Sep. 30, 2023 $ 10,552 $ 1 $ 27,590 $ (17,037) $ (2)